Fused Cytomembrane-Camouflaged Nanoparticles for Tumor-Specific Immunotherapy.
Sign Up to like & getrecommendations! Published in 2023 at "Advanced healthcare materials"
DOI: 10.1002/adhm.202300323
Abstract: Tumor immunotherapy is commonly hindered by inefficient delivery and presentation of tumor antigens as well as immunosuppressive tumor microenvironment. To overcome these barriers, we report a tumor-specific nanovaccine capable of delivering tumor antigens and adjuvants to… read more here.
Keywords: tumor specific; immunotherapy; fused cytomembrane; tumor ... See more keywords